{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:02:16Z","timestamp":1773284536271,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T00:00:00Z","timestamp":1240185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-230x-9-25","type":"journal-article","created":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T06:17:33Z","timestamp":1240294653000},"source":"Crossref","is-referenced-by-count":58,"title":["Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974\u20132002"],"prefix":"10.1186","volume":"9","author":[{"given":"Michael","family":"Hermansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Ekedahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Ranstam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,20]]},"reference":[{"issue":"6","key":"317_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3109\/00365529709025093","volume":"32","author":"M Hermansson","year":"1997","unstructured":"Hermansson M, Stael von Holstein C, Zilling T: Peptic ulcer perforation before and after the introduction of H2-receptor blockers and proton pump inhibitors. Scand J Gastroenterol. 1997, 32 (6): 523-529. 10.3109\/00365529709025093.","journal-title":"Scand J Gastroenterol"},{"issue":"14","key":"317_CR2","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","volume":"160","author":"S Hernandez-Diaz","year":"2000","unstructured":"Hernandez-Diaz S, Rodriguez LA: Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000, 160 (14): 2093-2099. 10.1001\/archinte.160.14.2093.","journal-title":"Arch Intern Med"},{"issue":"7528","key":"317_CR3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/bmj.331.7528.1310","volume":"331","author":"J Hippisley-Cox","year":"2005","unstructured":"Hippisley-Cox J, Coupland C, Logan R: Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. Bmj. 2005, 331 (7528): 1310-1316. 10.1136\/bmj.331.7528.1310.","journal-title":"Bmj"},{"issue":"9300","key":"317_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","volume":"359","author":"JQ Huang","year":"2002","unstructured":"Huang JQ, Sridhar S, Hunt RH: Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002, 359 (9300): 14-22. 10.1016\/S0140-6736(02)07273-2.","journal-title":"Lancet"},{"issue":"3","key":"317_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1053\/gast.1997.v112.pm9041228","volume":"112","author":"A Lanas","year":"1997","unstructured":"Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sainz R: Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology. 1997, 112 (3): 683-689. 10.1053\/gast.1997.v112.pm9041228.","journal-title":"Gastroenterology"},{"issue":"1","key":"317_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/pds.561","volume":"10","author":"MJ Langman","year":"2001","unstructured":"Langman MJ: Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?. Pharmacoepidemiol Drug Saf. 2001, 10 (1): 13-19. 10.1002\/pds.561.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"317_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/00001648-199701000-00003","volume":"8","author":"SP Gutthann","year":"1997","unstructured":"Gutthann SP, Garcia Rodriguez LA, Raiford DS: Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology. 1997, 8 (1): 18-24. 10.1097\/00001648-199701000-00003.","journal-title":"Epidemiology"},{"issue":"4","key":"317_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/gut.37.4.509","volume":"37","author":"J Slattery","year":"1995","unstructured":"Slattery J, Warlow CP, Shorrock CJ, Langman MJ: Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin\u2013analysis of gastrointestinal bleeding during the UK-TIA trial. Gut. 1995, 37 (4): 509-511. 10.1136\/gut.37.4.509.","journal-title":"Gut"},{"issue":"6983","key":"317_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","volume":"310","author":"J Weil","year":"1995","unstructured":"Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P: Prophylactic aspirin and risk of peptic ulcer bleeding. Bmj. 1995, 310 (6983): 827-830.","journal-title":"Bmj"},{"issue":"9","key":"317_CR10","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/j.1572-0241.2000.02248.x","volume":"95","author":"HT Sorensen","year":"2000","unstructured":"Sorensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH: Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol. 2000, 95 (9): 2218-2224.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"317_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/gut.50.4.460","volume":"50","author":"J Higham","year":"2002","unstructured":"Higham J, Kang JY, Majeed A: Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut. 2002, 50 (4): 460-464. 10.1136\/gut.50.4.460.","journal-title":"Gut"},{"issue":"2","key":"317_CR12","first-page":"369","volume":"6","author":"J Janik","year":"2000","unstructured":"Janik J, Chwirot P: Perforated peptic ulcer\u2013time trends and patterns over 20 years. Med Sci Monit. 2000, 6 (2): 369-372.","journal-title":"Med Sci Monit"},{"issue":"1","key":"317_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/bjs.1800780110","volume":"78","author":"H Paimela","year":"1991","unstructured":"Paimela H, Tuompo PK, Perakyl T, Saario I, Hockerstedt K, Kivilaakso E: Peptic ulcer surgery during the H2-receptor antagonist era: a population-based epidemiological study of ulcer surgery in Helsinki from 1972 to 1987. Br J Surg. 1991, 78 (1): 28-31. 10.1002\/bjs.1800780110.","journal-title":"Br J Surg"},{"issue":"8479","key":"317_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(86)92940-5","volume":"1","author":"R Walt","year":"1986","unstructured":"Walt R, Katschinski B, Logan R, Ashley J, Langman M: Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet. 1986, 1 (8479): 489-492. 10.1016\/S0140-6736(86)92940-5.","journal-title":"Lancet"},{"issue":"8","key":"317_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1365-2036.2007.03274.x","volume":"25","author":"S Christensen","year":"2007","unstructured":"Christensen S, Riis A, Norgaard M, Thomsen RW, Sorensen HT: Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer. Aliment Pharmacol Ther. 2007, 25 (8): 907-912.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"317_CR16","first-page":"603","volume":"91","author":"AC Nilsson","year":"1994","unstructured":"Nilsson AC, Spetz CL, Carsjo K, Nightingale R, Smedby B: [Reliability of the hospital registry. The diagnostic data are better than their reputation]. Lakartidningen. 1994, 91 (7): 603-595.","journal-title":"Lakartidningen"},{"issue":"3","key":"317_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/0016-5085(88)90240-5","volume":"94","author":"S Gustavsson","year":"1988","unstructured":"Gustavsson S, Kelly KA, Melton LJ, Zinsmeister AR: Trends in peptic ulcer surgery. A population-based study in Rochester, Minnesota, 1956\u20131985. Gastroenterology. 1988, 94 (3): 688-694.","journal-title":"Gastroenterology"},{"issue":"9","key":"317_CR18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/oxfordjournals.aje.a117519","volume":"141","author":"C Svanes","year":"1995","unstructured":"Svanes C, Lie RT, Kvale G, Svanes K, Soreide O: Incidence of perforated ulcer in western Norway, 1935\u20131990: cohort- or period-dependent time trends?. Am J Epidemiol. 1995, 141 (9): 836-844.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"317_CR19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/00000658-198610000-00014","volume":"204","author":"CE Welch","year":"1986","unstructured":"Welch CE, Rodkey GV, von Ryll Gryska P: A thousand operations for ulcer disease. Ann Surg. 1986, 204 (4): 454-467. 10.1097\/00000658-198610000-00014.","journal-title":"Ann Surg"},{"issue":"5","key":"317_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1440-1746.1992.tb01029.x","volume":"7","author":"SK Lam","year":"1992","unstructured":"Lam SK, Byth K, Ng MM, Hui WM, McIntosh J, Piper DW: Perforated peptic ulcer in Hong Kong and New South Wales. J Gastroenterol Hepatol. 1992, 7 (5): 508-511. 10.1111\/j.1440-1746.1992.tb01029.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"317_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000079654","volume":"21","author":"H Paimela","year":"2004","unstructured":"Paimela H, Oksala NK, Kivilaakso E: Surgery for peptic ulcer today. A study on the incidence, methods and mortality in surgery for peptic ulcer in Finland between 1987 and 1999. Dig Surg. 2004, 21 (3): 185-191. 10.1159\/000079654.","journal-title":"Dig Surg"},{"issue":"1","key":"317_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00000658-198801000-00002","volume":"207","author":"A Christensen","year":"1988","unstructured":"Christensen A, Bousfield R, Christiansen J: Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists. Ann Surg. 1988, 207 (1): 4-6. 10.1097\/00000658-198801000-00002.","journal-title":"Ann Surg"},{"issue":"2","key":"317_CR23","first-page":"144","volume":"39","author":"J Makela","year":"1992","unstructured":"Makela J, Laitinen S, Kairaluoma MI: Complications of peptic ulcer disease before and after the introduction of H2-receptor antagonists. Hepatogastroenterology. 1992, 39 (2): 144-148.","journal-title":"Hepatogastroenterology"},{"issue":"8\u20139","key":"317_CR24","first-page":"446","volume":"168","author":"JT Makela","year":"2002","unstructured":"Makela JT, Kiviniemi H, Ohtonen P, Laitinen SO: Factors that predict morbidity and mortality in patients with perforated peptic ulcers. Eur J Surg. 2002, 168 (8\u20139): 446-451.","journal-title":"Eur J Surg"},{"issue":"5","key":"317_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1590-8658(02)80124-4","volume":"34","author":"DS Canoy","year":"2002","unstructured":"Canoy DS, Hart AR, Todd CJ: Epidemiology of duodenal ulcer perforation: a study on hospital admissions in Norfolk, United Kingdom. Dig Liver Dis. 2002, 34 (5): 322-327. 10.1016\/S1590-8658(02)80124-4.","journal-title":"Dig Liver Dis"},{"issue":"8","key":"317_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1080\/00365520510015809","volume":"40","author":"C Ohmann","year":"2005","unstructured":"Ohmann C, Imhof M, Ruppert C, Janzik U, Vogt C, Frieling T, Becker K, Neumann F, Faust S, Heiler K: Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol. 2005, 40 (8): 914-920. 10.1080\/00365520510015809.","journal-title":"Scand J Gastroenterol"},{"issue":"8233","key":"317_CR27","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(81)92470-3","volume":"1","author":"D Coggon","year":"1981","unstructured":"Coggon D, Lambert P, Langman MJ: 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet. 1981, 1 (8233): 1302-1304. 10.1016\/S0140-6736(81)92470-3.","journal-title":"Lancet"},{"issue":"12","key":"317_CR28","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.2105\/AJPH.72.12.1336","volume":"72","author":"H Morgenstern","year":"1982","unstructured":"Morgenstern H: Uses of ecologic analysis in epidemiologic research. Am J Public Health. 1982, 72 (12): 1336-1344. 10.2105\/AJPH.72.12.1336.","journal-title":"Am J Public Health"},{"issue":"4","key":"317_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/gut.26.4.359","volume":"26","author":"DS Collier","year":"1985","unstructured":"Collier DS, Pain JA: Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut. 1985, 26 (4): 359-363. 10.1136\/gut.26.4.359.","journal-title":"Gut"},{"issue":"4","key":"317_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/bjs.1800640406","volume":"64","author":"TG Jorgensen","year":"1977","unstructured":"Jorgensen TG: Drug consumption before perforation of peptic ulcer. Br J Surg. 1977, 64 (4): 247-249. 10.1002\/bjs.1800640406.","journal-title":"Br J Surg"},{"issue":"3","key":"317_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/gut.46.3.310","volume":"46","author":"CJ Hawkey","year":"2000","unstructured":"Hawkey CJ: Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs. Gut. 2000, 46 (3): 310-311. 10.1136\/gut.46.3.310.","journal-title":"Gut"},{"issue":"1","key":"317_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/infdis\/168.1.219","volume":"168","author":"N Banatvala","year":"1993","unstructured":"Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA: The cohort effect and Helicobacter pylori. J Infect Dis. 1993, 168 (1): 219-221.","journal-title":"J Infect Dis"},{"issue":"4","key":"317_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/00004836-199712000-00006","volume":"25","author":"K Haruma","year":"1997","unstructured":"Haruma K, Okamoto S, Kawaguchi H, Gotoh T, Kamada T, Yoshihara M, Sumii K, Kajiyama G: Reduced incidence of Helicobacter pylori infection in young Japanese persons between the 1970s and the 1990s. J Clin Gastroenterol. 1997, 25 (4): 583-586. 10.1097\/00004836-199712000-00006.","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"317_CR34","first-page":"1480","volume":"92","author":"R Roosendaal","year":"1997","unstructured":"Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM: Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol. 1997, 92 (9): 1480-1482.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"317_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","volume":"12","author":"D Cullen","year":"1998","unstructured":"Cullen D, Bardhan KD, Eisner M, Kogut DG, Peacock RA, Thomson JM, Hawkey CJ: Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther. 1998, 12 (2): 135-140. 10.1046\/j.1365-2036.1998.00288.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"317_CR36","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3109\/00365529609010347","volume":"31","author":"P Ekstrom","year":"1996","unstructured":"Ekstrom P, Carling L, Wetterhus S, Wingren PE, Anker-Hansen O, Lundegardh G, Thorhallsson E, Unge P: Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol. 1996, 31 (8): 753-758. 10.3109\/00365529609010347.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"317_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"CJ Hawkey","year":"1998","unstructured":"Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998, 338 (11): 727-734. 10.1056\/NEJM199803123381105.","journal-title":"N Engl J Med"},{"issue":"11","key":"317_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM199803123381104","volume":"338","author":"ND Yeomans","year":"1998","unstructured":"Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998, 338 (11): 719-726. 10.1056\/NEJM199803123381104.","journal-title":"N Engl J Med"},{"issue":"3","key":"317_CR39","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/ar2207","volume":"9","author":"HE Vonkeman","year":"2007","unstructured":"Vonkeman HE, Fernandes RW, Palen van der J, van Roon EN, Laar van de MA: Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Arthritis Res Ther. 2007, 9 (3): R52-10.1186\/ar2207.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"317_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1523-5378.2003.00139.x","volume":"8","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Pajares JM: Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment. Helicobacter. 2003, 8 (3): 159-167. 10.1046\/j.1523-5378.2003.00139.x.","journal-title":"Helicobacter"},{"issue":"10","key":"317_CR41","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1136\/gut.34.10.1344","volume":"34","author":"DH Reinbach","year":"1993","unstructured":"Reinbach DH, Cruickshank G, McColl KE: Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut. 1993, 34 (10): 1344-1347. 10.1136\/gut.34.10.1344.","journal-title":"Gut"},{"issue":"8","key":"317_CR42","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1046\/j.0007-1323.2001.01831.x","volume":"88","author":"V Kate","year":"2001","unstructured":"Kate V, Ananthakrishnan N, Badrinath S: Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies. Br J Surg. 2001, 88 (8): 1054-1058. 10.1046\/j.0007-1323.2001.01831.x.","journal-title":"Br J Surg"},{"issue":"2","key":"317_CR43","first-page":"208","volume":"58","author":"JC Debongnie","year":"1995","unstructured":"Debongnie JC, Wibin E, Timmermans M, Mairesse J, Dekoninck X: Are perforated gastroduodenal ulcers related to Helicobacter pylori infection?. Acta Gastroenterol Belg. 1995, 58 (2): 208-212.","journal-title":"Acta Gastroenterol Belg"},{"issue":"10","key":"317_CR44","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/003655298750026705","volume":"33","author":"AE Henriksson","year":"1998","unstructured":"Henriksson AE, Edman AC, Nilsson I, Bergqvist D, Wadstrom T: Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer. Scand J Gastroenterol. 1998, 33 (10): 1030-1033. 10.1080\/003655298750026705.","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 1","key":"317_CR45","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.1097\/00004836-199700001-00037","volume":"25","author":"N Matsukura","year":"1997","unstructured":"Matsukura N, Onda M, Tokunaga A, Kato S, Yoshiyuki T, Hasegawa H, Yamashita K, Tomtitchong P, Hayashi A: Role of Helicobacter pylori infection in perforation of peptic ulcer: an age- and gender-matched case-control study. J Clin Gastroenterol. 1997, 25 (Suppl 1): S235-239. 10.1097\/00004836-199700001-00037.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"317_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1440-1746.2003.02889.x","volume":"18","author":"A Okan","year":"2003","unstructured":"Okan A, Tankurt E, Aslan BU, Akpinar H, Simsek I, Gonen O: Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study. J Gastroenterol Hepatol. 2003, 18 (1): 18-25. 10.1046\/j.1440-1746.2003.02889.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"317_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2036.2002.0160s1003.x","volume":"16","author":"MF Go","year":"2002","unstructured":"Go MF: Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002, 16 (Suppl 1): 3-15. 10.1046\/j.1365-2036.2002.0160s1003.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"317_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0016-5107(99)70345-7","volume":"50","author":"KM Chu","year":"1999","unstructured":"Chu KM, Kwok KF, Law SY, Tuen HH, Tung PH, Branicki FJ, Wong J: Helicobacter pylori status and endoscopy follow-up of patients having a history of perforated duodenal ulcer. Gastrointest Endosc. 1999, 50 (1): 58-62. 10.1016\/S0016-5107(99)70345-7.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"317_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00000658-200002000-00001","volume":"231","author":"EK Ng","year":"2000","unstructured":"Ng EK, Lam YH, Sung JJ, Yung MY, To KF, Chan AC, Lee DW, Law BK, Lau JY, Ling TK, et al: Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg. 2000, 231 (2): 153-158. 10.1097\/00000658-200002000-00001.","journal-title":"Ann Surg"},{"issue":"3","key":"317_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/bjs.1800820325","volume":"82","author":"M Sebastian","year":"1995","unstructured":"Sebastian M, Chandran VP, Elashaal YI, Sim AJ: Helicobacter pylori infection in perforated peptic ulcer disease. Br J Surg. 1995, 82 (3): 360-362. 10.1002\/bjs.1800820325.","journal-title":"Br J Surg"},{"issue":"4","key":"317_CR51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/00001648-200007000-00012","volume":"11","author":"IB Andersen","year":"2000","unstructured":"Andersen IB, Jorgensen T, Bonnevie O, Gronbaek M, Sorensen TI: Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology. 2000, 11 (4): 434-439. 10.1097\/00001648-200007000-00012.","journal-title":"Epidemiology"},{"key":"317_CR52","volume-title":"Unders\u00f6kningarna av levnadsf\u00f6rh\u00e5llanden (ULF)","author":"Swedish-central-bureau-of-statistics (SCB)","year":"2006","unstructured":"Swedish-central-bureau-of-statistics (SCB): Unders\u00f6kningarna av levnadsf\u00f6rh\u00e5llanden (ULF). 2006, [\n                    http:\/\/www.scb.se\n                    \n                  ]"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-9-25\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-9-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-9-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-9-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T12:32:18Z","timestamp":1548246738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-9-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,20]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-9-25","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,20]]},"article-number":"25"}}